I'm guessing not....
Much to no ones surprise, you know nothing about corporate officer responsibilities. Mc has a fiduciary duty to promote the company. This is one way that can't be disapproved by MDT. These are legitimate efforts to support the company/product/R&D Lab as PR. Oh, and the share price.
With $50M in cash, and another approximately $10M to be paid upon completion of the 4th milestone (Net of the loan payment) it would be highly doubtful.
After the 4th milestone, AND the loan payoff, the gloves come off. We're free to negotiate with anyone, anytime. That would put MDT in a dire situation. Do you think anyone would sell, knowing that news of any kind regarding TMDI and another medical device mfr., or news from MDT would rocket the sp?
The further down the road we get, with more IP - the more expensive we become. Whether MDT makes an offer, or anyone else. Do you doubt that there's more than casual interest from ISRG?
Do tell us how MDT will make a SP RAS from 12-15 patents to compete against ENOS, and with a different medical device manufacturer? How long will it take MDT to build that sp robot? How much more money will that take? Will MDT BoD ask Martha what he's thinking when they say, "Um, you have 15 patents?" "And you want to make another SP that may take longer than 5 years?" "When there's one available, with over 200 patents?" You funny! I'd buy a ticket to listen in on that meeting.
Having MDT as a partner, with co-licensed IP is like having a room full of corporate patent lawyers. Exactly like that. How convenient.
Don't you just love a VERY LARGE RAS device manufacturer CEO with a spending jones?
Good luck to all. Regards,BK.
